Liver cells were isolated on Ficoll/Hypaque gradients from embryos or fetuses at 6-10 weeks of gestation; 2-20% of the cells expressed CD45 or HLA class I surface antigens and 2-6% expressed CD7. Other T-or natural-killer (NK)-cell-lineage-specific markers were undetectable. Livercell suspensions cultured in the presence of phytohemagglutinin and recombinant interleukin 2 gave rise to large proportions of CD3+ lymphocytes expressing either a/,B or y/6 T-cell receptors. This occurred not only in bulk cultures but also when cells were cloned under limiting dilution conditions. Importantly, these figures were obtained also in embryos at 6-8 weeks of gestation, which is before colonization of the thymic rudiment by T-cell precursors. When the same liver-cell suspensions were cultured in the presence of irradiated H9 cells and recombinant interleukin 2 (either in bulk cultures or under cloning conditions), large proportions of cells (or clones) expressed surface CD16 and CD56 antigens and displayed a strong cytolytic activity against both NK-sensitive (K562) and NK-resistant (M14) target cells. In addition, liver-derived T or NK cells expressed functional receptor molecules since they could be activated via either CD3/T-cell receptor or CD16 surface antigens, respectively. Further fractionation of liver cells on the basis of CD45 antigen expression indicated that only CD45+ cells could give rise to T or NK cells in culture. Thus, CD45 can be used as a marker for identification of an early liver-cell population containing T-and NK-cell precursors.
That T or NK cells were derived from male embryos and not from the mother was shown by PCR amplification of X and Y chromosomal sequences. Our present data may offer an in vitro model for extrathymic embryonic T-cell maturation that can be used to examine fundamental aspects of human T-cell development and function.
The embryonic/fetal liver contains precursors of both the myeloid (1) and lymphoid (2-5) cell lineages. However, it is commonly accepted that major histocompatibility complexrestricted antigen-reactive T lymphocytes further require the thymus for their maturation. Thus, mature T lymphocytes develop from fetal-liver-derived progenitors that colonize the human fetal thymus between 8 and 9 weeks of gestation (2, 3) . No mature T lymphocytes have been detected before this gestational age. Recently, CD3-CD4-CD8-CD16-thymic precursors were shown to give rise in vitro to either CD3-CD16+ natural killer (NK) cells or CD3+ T-cellreceptor-positive (TCR+) T lymphocytes, depending on the culture conditions (i.e., type of feeder cells and/or stimulus) (6, 7) . Here, we analyzed liver cells from virtually intact embryos or fetuses at 6-10 weeks of gestation (8) . We show that fetal liver cells were induced to undergo both proliferation and maturation toward either T lymphocytes expressing a functional CD3/TCR complex (a//3 or y/8) or CD3-CD16+ NK cells, the differentiation pathway depending on the culture conditions. It is of note that these results could be obtained also with liver cells from embryos at 6-8 weeks of gestation, which is before colonization of the thymic rudiment by lymphoid precursors. Finally, all fetal-liver-derived T-and NK-cell precursors were confined to a small subset expressing CD45 surface antigen.
MATERIALS AND METHODS Antibodies and Reagents. Monoclonal antibodies (mAbs)
Hle-1 (anti-CD45), Leu9 (anti-CD7), Leu5b (anti-CD2), Leu4 (anti-CD3), Leu2a (anti-CD8), Leulla,b,c (anti-CD16), anti-HPCA-1 (anti-CD34), anti-My9 (anti-CD33), anti-TCR1 (WT31), and anti-interleukin 2 (IL-2) receptor (anti-CD25) were purchased from Becton Dickinson. Anti-HLA class I mAb (W6/32) was from Dakopatts (Glostrup, Denmark).
VD4 (anti-CD16) (9), KD1 (anti-CD16) (9), A13 (anti-V8-1) (10) , BB3 (anti-VS-2) (10), and JT3A (anti-CD3) (11) mAbs were obtained in this laboratory. D1-12 (anti-DR) and UCHT-1 (anti-CD3) mAbs were generous gifts of R. Accolla (Istituto di Scienze Immunologiche, Verona, Italy) and P. C. L. Beverley (Imperial Cancer Research Fund, London), respectively. Anti-TCR61 and anti-TCR'y/81 mAbs, which recognize all TCRy/8+ cells, were kindly provided by M. B. Brenner (Dana-Farber Cancer Institute, Boston) and R. L. H. Bolhuis (Radio-Therapeutic Institute, Rotterdam, The Netherlands), respectively. Fluorescein isothiocyanateconjugated anti-isotype-specific goat anti-mouse immunoglobulin was purchased from Southern Biotechnology Associates (Birmingham, AL). Phytohemagglutinin (PHA), RPMI 1640 medium, L-glutamine, and penicillin/streptomycin were purchased from Biochrom (Berlin). Recombinant (r) IL-2 was kindly provided by Cetus.
Isolation of Cells from Liver or the Upper Part of Thorax of Embryos or Fetuses. The liver and the upper part of thorax from 6-to 8-week embryos and 9-to 10-week fetuses were obtained during legal curettage abortions at 6-10 weeks of gestation. All the embryos and fetuses analyzed were virtually intact. Gestational age was evaluated on the basis of morphological staging according to multiple criteria including age vs. crown-rump length plots. The integrity of the examined embryos and fetuses gave a dating error of as little as ±2 days (8 Cloning of Liver Cells. Cloning of liver cells isolated from embryos (6-8 weeks of gestation) or fetuses (9-10 weeks of gestation) was performed under limiting dilution conditions as described (12) in complete RPMI 1640 medium with rIL-2 (100 units/ml) in 200 ,ul in 96-well U-bottomed microplates (Greiner). The number of cells plated per well and the calculation of the cloning efficiencies (Q1%) were based on CD45+ cells present in a given cell suspension. Microcultures contained 105 irradiated peripheral blood lymphocytes with or without 2 x 104 irradiated H9 cells per well, in the presence or in the absence of 0.5% PHA, respectively. Cell growth could be detected after 20-25 days of culture. Clones were further maintained in culture for 2-4 weeks.
Analysis of Cytolytic Activity. Cytolytic activity of liverderived clones against NK-sensitive (erythroleukemia cell line K562) and NK-resistant (melanoma cell line M14) target cells was tested in a 4-h 51Cr release assay, and the percent of specific 51Cr release was determined as described (13) . In the redirected killing assay, we used P815 (positive for Fc receptors for mouse IgG, FcyR', murine mastocitoma) as target cells and anti-CD3 (JT3A or UCHT-1), anti-CD16 (KD1), or anti-CD7 (Leu9) mAbs at 20 ng/ml as described (9) .
Sex Assessment of Lymphoid Populations Derived from Embryonic or Fetal Liver. Genomic DNA was extracted as described (14) from CD3+ or CD3-CD16+ polyclonal or clonal populations derived from human embryonic or fetal liver at 7-9 weeks of gestation. Polymerase chain reaction (PCR) was performed on 500 ng from these samples by using a pair of oligodeoxynucleotide primers derived from homologous sequences of the X and Y chromosomes (15) . The amplified DNA was loaded and size-fractionated on a 1% agarose gel as described (14) . By using this technique, we could simultaneously amplify the X and Y sequences in our samples. As male and female controls, we used DNA derived from two Epstein-Barr virus-infected B-cell lines. Control female DNA showed only one 970-bp band, whereas control male DNA gave an additional band that was 177 bp shorter and specific for the Y chromosome.
RESULTS AND DISCUSSION Surface Markers of Liver Cells Isolated from Embryos or
Fetuses. Liver-cell suspensions isolated from 15 specimens (embryos or fetuses at 6-10 weeks of gestation) were analyzed for a number of informative surface markers. As shown in Table 1 , 2-20% of cells expressed the common leukocyte antigen CD45 or HLA class I molecules and 2-6% of cells expressed CD7, whereas cells expressing CD2, CD3, CD56, and CD16 were virtually undetectable. In addition, no cells expressed CD4, CD8, or CD25 antigens (data not shown). These data are in keeping with the demonstration that mature T cells are not detectable in the liver before the 13th week of gestation (16) . It is noteworthy that parallel analysis of cell suspensions obtained from the upper part of thorax of two embryos at 6 and 8 weeks of gestation, respectively, showed no cells expressing the above markers, with the exception of CD56 (present on "40% of cells) and most likely representative of a nonlymphoid population. These results indicate that both liver and the upper part of thorax do not contain mature T cells before the 9th week of gestation.
Proliferation of CD3+TCR+ or CD3-CD16+ Cells from Liver Precursors. In all instances fetal liver cells underwent proliferation when cultured in the presence of rIL-2 and PHA; liver-cell fractionation on the basis of CD45 antigen expression indicated that the proliferating population was derived from the small CD45+ cell subset. Indeed, up to a 200-fold increase ofthe original input of CD45+ cells could be detected after 3-4 weeks of culture. In contrast, the CD45-subset did not proliferate under the same conditions. More importantly, the population of CD45+ cells undergoing pro- 6 3. The same fetal liver cell populations (i.e., the unfractionated or the CD45+ subpopulation) were cultured in the presence of irradiated H9 feeder cells and rIL-2. Under these culture conditions, the proliferating cells after 2-3 weeks of culture were mainly represented by CD3-CD16+CD56+ populations (Fig. 1, row B) .
Cloning of Liver Cells Under Limiting Dilution. Liver cells isolated from five embryos or fetuses at 6-9 weeks of gestation were cultured under limiting dilution conditions in the presence of either PHA and rIL-2 or H9 cells and rIL-2, and the resulting clones were analyzed for their phenotypic and functional characteristics (Fig. 1, rows D-F Table 2 , appropriate mAbs (anti-CD16 or anti-CD3) triggered target-cell lysis by representative NK-or T-cell clones. Interestingly, the majority (>80%) of CD4+ clones analyzed displayed cytolytic activity after triggering with anti-CD3 mAbs (Table 2) . derived under limiting dilution conditions, in the presence of either PHA and IL-2 (T-cell clones) or irradiated H9 cells and IL-2 (NK clones). The cytolytic activity of representative clones was tested in a 4-h 51Cr release assay. The effector/target (E/T) ratios used in the test are indicated for the target cells identified. The mAbs used in the redirected killing assay are the following: JT3A and UCHT-1 (anti-CD3), KD1 (anti-CD16), and Leu9 (anti-CD7). These mAbs were stimuli added to the cytolytic test. Note that clone B12FF displayed a male phenotype (see also Results and Discussion and Fig. 2 ).
Further analysis of the cytolytic activity of liver-derived Tor NK-cell clones indicated that CD3-CD16+ clones efficiently lysed both K562 (NK sensitive) and M14 (NK resistant) target cells. On the other hand, CD3+ clones displayed a variable, but usually low, cytolytic activity against these targets ( Table 2) .
Proliferating CD3+TCR+ or CD3-CD16+ Lymphocytes Are Derived from the Embryo but Not from the Mother. To exclude possible contamination of fetal male liver cells with mother-derived lymphocytes, we performed PCR amplification using the X-Y homologous primer technique (15) with DNA extracted from cultured CD3+TCR+ or CD3-CD16+ lymphocyte populations or clones derived from two embryos at 7 and 8 weeks and a fetus at 9 weeks ofgestation. As shown in Fig. 2 , two of the three samples analyzed (the B12FF CD3/TCR+ clone derived from a 7-week embryo and a polyclonal population of 9 weeks) showed two bands (one specific for X sequences and the other specific for Y sequences), typical of the male phenotype. The third sample, a polyclonal population from an 8-week embryo, resulted in a single band (specific for an X sequence) typical of the female phenotype (data not shown). These data clearly indicate (at least in two of three cases analyzed) that the lymphocyte populations or clones undergoing in vitro expansion were derived from the male embryo and not from the mother.
Our data demonstrate that CD3+ lymphocytes equipped with functional TCRs can originate in vitro from fetal liver cells lacking all detectable T-cell lineage markers. In addition, in agreement with previous reports, we show that lymphocyte populations or clones derived from human embryonic and fetal liver at 7 and 9 weeks of gestation, respectively. As male and female controls, we used DNA derived from two Epstein-Barr virus-infected B-cell lines (lanes a and b, respectively) . The 7-week (the B12FF CD3/TCR+ clone) and 9-week (a polyclonal population) (in lanes c and d, respectively) samples showed the two bands typical of the male phenotype. Molecular sizes in bp are shown.
CD3-CD16+ NK cells may be derived from fetal liver under appropriate culture conditions (20) .
Previous studies indicated that CD3+ cells were obtained from rIL-2-cultured liver cells isolated from fetuses at 12.5 weeks ofgestation (2) . Our studies are in line with these data. More importantly, they show that mature T cells equipped with functional TCRs can be derived also from embryos at 6-8 weeks of gestation, which is before the earliest colonization of the epithelial thymus with lymphoid precursors (2, 3) . In addition, CD3+TCR+ cells could not be generated from cells isolated from the upper part of thorax of embryos of the same gestational age. These data clearly indicate that liverderived proliferating lymphocytes are not thymic emigrants, but they are rather derived from liver precursors.
Further dissection of embryonic liver cells was possible on the basis of CD45 antigen expression. It is noteworthy that small proportions of CD45+ cells had been described in 7-week fetal liver (2, 19) . Although CD45+ cells represented only a minor fraction of liver cells, also in our studies, the precursors of both T lymphocytes and NK cells were uniquely contained in this phenotypically defined subset. Our present data are consistent with the concept that the fetal or embryonic liver contains precursors that are committed to the T-cell (or to the NK-cell) lineage. If this is the case, appropriate maturational signals would be sufficient for these committed precursors to undergo maturation into CD3+TCR+ cells (or NK cells). An alternative interpretation, equally compatible with our data, is that the liver precursors of T and NK cells are represented by uncommitted lymphoid precursors or pluripotent stem cells. If this is the case, the culture conditions used in our experiments would mimic the microenvironment (e.g., thymus) needed to induce differentiation of lymphoid precursors into mature T or NK cells. Along the same line, recent data in the mouse have shown that an early fetal Fc receptor Il/III-positive lymphoid population matures in vivo into functional T lymphocytes or NK cells, depending on the type of microenvironment provided (21) . These data, and our present experiments, do not clarify whether T and NK cells are derived from the same or different cell precursors. It is evident that the solution to this problem would be offered only by the development of culture conditions that allow, in single-cell assays, optimal maturation toward different hemopoietic cell lineages (including T and NK cells). Along this line, fetal liver cells have been shown to include myeloid precursors that give rise to mixed colonies including both erythroid [erythroid burst-forming units (BFU-E), and colony-forming units (CFU-E)] and granulo-monocytic [granulocyte-macrophage colony-forming units (CFU-GM)] cells. It is perhaps worth noting that, under physiological in vivo conditions (i.e., erythropoietin release), fetal liver cells almost exclusively undergo differentiation/ maturation to BFU-E/CFU-E, whereas in vitro addition of appropriate growth factors induces differentiation/maturation of not only BFU-E/CFU-E but also CFU-GM (1). As we show here, a subset of fetal liver cells characterized by CD45 antigen expression could also undergo maturation/ differentiation toward lymphoid lineages when cultured with appropriate stimuli and growth factors.
Whatever the interpretation of our present results, the possibility of inducing T-cell maturation from liver precursors may provide insight in the mechanism of T-cell maturation and selection. For example, this model system can be applied (i) to determine whether CD3+/TCR+ cells derived from fetal liver in vitro utilize a large or, rather, a limited number of TCR variable segments (22) and (ii) to define whether autoreactive clones exist among T (and NK)-cell clones derived from fetal liver (23) (24) (25) .
Note Added in Proof. Sanchez et al. (26) , after this article was submitted, reported the phenotype and molecular characterization of putative prethymic T-cell precursors in the early human embryonic liver and proposed that primitive fetal liver hematopoietic CD3/ TCR-progenitors may differentiate into CD3/TCR+ lymphocytes when cocultured with thymus-derived epithelial cells.
